We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOFT icon
2501
Hooker Furnishings Corp
HOFT
$166M
$577K ﹤0.01%
16,659
-2,362
-12% -$88K
TCRT icon
2502
Alaunos Therapeutics
TCRT
$4.86M
$577K ﹤0.01%
1,457
-366
-20% -$171K
BFC icon
2503
Bank First Corp
BFC
$1.7B
$576K ﹤0.01%
8,254
+2,081
+34% +$149K
DTIL icon
2504
Precision BioSciences
DTIL
$207M
$574K ﹤0.01%
1,528
-118
-7% -$35.4K
KROS icon
2505
Keros Therapeutics
KROS
$221M
$574K ﹤0.01%
13,505
-170
-1% -$9.21K
HYFM icon
2506
Hydrofarm Holdings
HYFM
$7.62M
$572K ﹤0.01%
969
-28
-3% -$16.5K
ACTG icon
2507
Acacia Research
ACTG
$470M
$571K ﹤0.01%
84,458
-7,650
-8% -$45.5K
CTLP
2508
DELISTED
Cantaloupe
CTLP
$571K ﹤0.01%
+48,135
New +$565K
HIFS icon
2509
Hingham Institution for Saving
HIFS
$663M
$571K ﹤0.01%
1,967
-284
-13% -$83.5K
EVER icon
2510
EverQuote
EVER
$906M
$570K ﹤0.01%
17,449
+1,783
+11% +$59.4K
FMNB icon
2511
Farmers National Banc Corp
FMNB
$929M
$565K ﹤0.01%
36,460
-5,485
-13% -$92.1K
RVI
2512
DELISTED
Retail Value Inc. Common Shares
RVI
$563K ﹤0.01%
282,154
-27,051
-9% -$48.1K
UEC icon
2513
Uranium Energy
UEC
$5.57B
$562K ﹤0.01%
211,212
-57,207
-21% -$172K
POWW icon
2514
Outdoor Holding Co
POWW
$247M
$560K ﹤0.01%
+57,169
New +$406K
RCKY icon
2515
Rocky Brands
RCKY
$369M
$559K ﹤0.01%
10,053
-1,097
-10% -$61.7K
MOFG
2516
DELISTED
MidWestOne Financial Group
MOFG
$556K ﹤0.01%
19,309
-2,839
-13% -$87.2K
PHAT icon
2517
Phathom Pharmaceuticals
PHAT
$692M
$556K ﹤0.01%
16,438
+5,048
+44% +$181K
KDNY
2518
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$556K ﹤0.01%
39,388
+23,340
+145% +$373K
BNFT
2519
DELISTED
Benefitfocus, Inc.
BNFT
$556K ﹤0.01%
39,447
-2,955
-7% -$41.7K
RFL icon
2520
Rafael Holdings
RFL
$107M
$554K ﹤0.01%
10,995
-4,594
-29% -$200K
ACEL icon
2521
Accel Entertainment
ACEL
$987M
$553K ﹤0.01%
46,573
-427
-0.9% -$5.3K
AMTB icon
2522
Amerant Bancorp
AMTB
$1.13B
$553K ﹤0.01%
25,885
-5,665
-18% -$119K
FPI
2523
Farmland Partners
FPI
$432M
$551K ﹤0.01%
45,756
-4,609
-9% -$59.2K
FRPH icon
2524
FRP Holdings
FRPH
$421M
$551K ﹤0.01%
19,776
-2,032
-9% -$56.2K
DJCO icon
2525
Daily Journal
DJCO
$778M
$546K ﹤0.01%
1,612
+220
+16% +$70.6K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.